Intracellular Metabolism of β- l -2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity
Open Access
- 1 April 2000
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (4) , 853-858
- https://doi.org/10.1128/aac.44.4.853-858.2000
Abstract
The intracellular metabolism of the β- l - enantiomer of 2′,3′-dideoxyadenosine (β- l -ddA) was investigated in HepG2 cells, human peripheral blood mononuclear cells (PBMC), and primary cultured human hepatocytes in an effort to understand the metabolic basis of its limited activity on the replication of human immunodeficiency virus and hepatitis B virus. Incubation of cells with 10 μM [2′,3′,8- 3 H]-β- l -ddA resulted in an increased intracellular concentration of β- l -ddA with time, demonstrating that these cells were able to transport β- l -ddA. However, it did not result in the phosphorylation of β- l -ddA to its pharmacologically active 5′-triphosphate (β- l -ddATP). Five other intracellular metabolites were detected and identified as β- l -2′,3′-dideoxyribonolactone, hypoxanthine, inosine, ADP, and ATP, with the last being the predominant metabolite, reaching levels as high as 5.14 ± 0.95, 8.15 ± 2.64, and 15.60 ± 1.74 pmol/10 6 cells at 8, 4, and 2 h in HepG2 cells, PBMC, and hepatocytes, respectively. In addition, a β-glucuronic derivative of β- l -ddA was detected in cultured hepatocytes, accounting for 12.5% of the total metabolite pool. Coincubation of hepatocytes in primary culture with β- l -ddA in the presence of increasing concentrations of 5′-methylthioadenosine resulted in decreased phosphorolysis of β- l -ddA and formation of associated metabolites. These results indicate that the limited antiviral activity of β- l -ddA is the result of its inadequate phosphorylation to the nucleotide level due to phosphorolysis and catabolism of β- l -ddA by methylthioadenosine phosphorylase (EC 2.4.2.28 ).Keywords
This publication has 14 references indexed in Scilit:
- Enzymatic Properties of the Unnatural β-l-Enantiomers of 2‘,3‘-Dideoxyadenosine and 2‘,3‘-Didehydro-2‘,3‘-dideoxyadenosineJournal of Medicinal Chemistry, 1997
- New Unnatural L-Nucleoside Enantiomers:From Their Stereospecific Synthesis to Their Biological ActivitiesNucleosides and Nucleotides, 1997
- Design and Synthesis of 2‘,3‘-Dideoxy- 2‘,3‘-didehydro-β-l-cytidine (β-l-d4C) and 2‘,3‘-Dideoxy-2‘,3‘-didehydro-β-l-5- fluorocytidine (β-l-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in VitroJournal of Medicinal Chemistry, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Synthesis of a Series of Purine 2′,3′-Dideoxy-L-Nucleoside Analogues as Potential Antiviral AgentsNucleosides and Nucleotides, 1995
- Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virusAntimicrobial Agents and Chemotherapy, 1995
- Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitroAntimicrobial Agents and Chemotherapy, 1994
- The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Methionine synthesis from 5'-methylthioadenosine by tumour cellsBiochemical Pharmacology, 1983